Drug interactions with antipsychotic agents incidence and therapeutic implications

Keyphrases

• Drug Interactions 100%
• Therapeutic Implications 100%
• Antipsychotics 100%
• Plasma Concentration 35%
• Cytochrome P450 Enzymes 35%
• Clinical Significance 14%
• Adverse Effects 14%
• Protein Binding 14%
• Metabolism 14%
• Anticonvulsant 14%
• Metabolic Enzymes 14%
• Isozymes 7%
• Antidepressants 7%
• CYP2C19 7%
• Cytochrome P450 2D6 (CYP2D6) 7%
• In Vivo Testing 7%
• Serotonin 7%
• 5-hydroxytryptamine 7%
• Pharmacokinetics 7%
• Pharmacodynamic Interactions 7%
• Pharmacodynamics 7%
• Inhibitory Activity 7%
• Tricyclic Antidepressants 7%
• Lithium 7%
• Carbamazepine 7%
• Atypical Antipsychotics 7%
• Pharmaceutics 7%
• Drug Combination 7%
• Schizophrenic Patients 7%
• Phenobarbital 7%
• Site Activity 7%
• Receptor Sites 7%
• Phase II Metabolism 7%
• Psychotic Disorders 7%
• Water-soluble 7%
• Absorption Distribution 7%
• Potential Drug Interactions 7%
• Anxiolytic 7%
• Therapeutic Effectiveness 7%
• Drug Type 7%
• Enzyme Inducer 7%
• Pharmacokinetic Interaction 7%
• Phase I Metabolism 7%
• Uncontrolled Study 7%
• Ailments 7%
• Phenobarbitone 7%
• 5-HT Reuptake Inhibitor 7%
• Metabolic Interaction 7%

Pharmacology, Toxicology and Pharmaceutical Science

• Typical Antipsychotic 100%
• Drug Interaction 100%
• Cytochrome P450 Isoenzyme 21%
• Adverse Event 14%
• Pharmacokinetics 14%
• Pharmacodynamics 14%
• Serotonin 14%
• Cytochrome P450 14%
• Anticonvulsive Agent 14%
• Phenobarbital 14%
• Digestant 14%
• Isoenzyme 7%
• Drug-Drug Interaction 7%
• Antidepressant 7%
• Receptor 7%
• CYP2D6 7%
• CYP2C19 7%
• Tricyclic Antidepressant 7%
• Psychotropic Agent 7%
• Carbamazepine 7%
• Atypical Antipsychotics 7%
• Antipsychotic 7%
• Psychosis 7%
• Anxiolytic 7%
• Cholinergic Receptor Blocking Agent 7%
• Pharmaceutics 7%
• Omeprazole 7%
• Reuptake Inhibitor 7%